IDT Australia Ltd
ASX:IDT
IDT Australia Ltd
ASX:IDT
Price:
0.096 AUD
-3.03%
Market Closed
Updated:
May 21, 2024
IDT Australia Ltd
Operating Expenses
|
IDT Australia Ltd
Operating Expenses Peer Comparison
Comparables:
MYX
NEU
BOT
PBP
C
CU6
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
IDT Australia Ltd
ASX:IDT
|
Operating Expenses
-AU$15.7m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Operating Expenses
-AU$255.9m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Operating Expenses
-AU$32.7m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-11%
|
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Operating Expenses
-AU$18.9m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-29%
|
|
|
Probiotec Ltd
ASX:PBP
|
Operating Expenses
-AU$46.2m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-7%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Operating Expenses
-AU$26.4m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is IDT Australia Ltd's Operating Expenses?
Operating Expenses
-15.7m
AUD
-15.7m
AUD
Based on the financial report for Dec 31, 2023, IDT Australia Ltd's Operating Expenses amounts to -15.7m AUD.
What is IDT Australia Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
2%
2%
Over the last year, the Operating Expenses growth was -20%. The average annual Operating Expenses growth rates for IDT Australia Ltd have been -13% over the past three years , and 2% over the past ten years .
You don't have any saved screeners yet
